| Application no. and date | 09837072.9 (espacenet) (Federated) (European Patent Register), 20091228 | | Patent/reg. no. and date | DK/EP 2379104, 20180228 | | Publication date | 20111026 | | Priority no. and date | US 142063 P, 20081231 | | EP pub. no. and date |
EP 2379104 20111026 | | Effective date | | | Applicant/owner | Revance Therapeutics, Inc., 7555 Gateway Boulevard
Newark, CA 94560, US | | Applicant ref. no. | P81801198DK00E | | Inventor | RUEGG, Curtis, L., 826 Shepard Way
Redwood City
CA 94062, US,
STONE, Hongran, F., 1799 Croner Ave.
Menlo Park
CA 94025, US,
WAUGH, Jacob, M., 425 First Street, 1801
San Francisco
CA 94105, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/08 (2006.01) , A61K 8/64 (2006.01) , A61Q 19/08 (2006.01) | | Title | Injicerbare botulinumtoksinformuleringer | | Int. application no. | US2009069576 | | Int. publication no. | WO2010078242 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
